Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-01-13
1994-03-22
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530385, A61K 3714, C07K 302, C07K 322, C07K 1522
Patent
active
052964655
ABSTRACT:
A blood substitute and plasma expander comprising a cross-linked, substantially endotoxin-free hemoglobin solution and process for preparing same. The process comprises fractionating whole blood, separating out a stromal-free, sterile hemoglobin solution, chromatographically separating endotoxins from said hemoglobin solution and crosslinking the resulting endotoxin-free hemoglobin solution.
REFERENCES:
patent: 3959128 (1976-05-01), Harris
patent: 4059512 (1977-11-01), Harris
patent: 4314997 (1982-02-01), Shanbrom et al.
patent: 4826811 (1989-05-01), Sehgal et al.
Feola et al., "Development of a Bovine Stromen Free Hemoglobin Solution . . . ", Surgery, Nov. 1983, vol. 157, pp. 399-408.
Feola Mario
Rausch Carl W.
Biopure Corporation
Russel Jeffrey E.
LandOfFree
Ultra pure hemoglobin solutions and blood-substitutes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ultra pure hemoglobin solutions and blood-substitutes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ultra pure hemoglobin solutions and blood-substitutes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437141